BackCytoMed Therapeutics Overview

CytoMed Therapeutics Current Assets

Track CytoMed Therapeutics's current assets ($3.7M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Current Assets
$3.66M
↓ 16.73% YoYΔ $-735722.00 vs prior year quarter

Peer trimmed avg / median

Loading

CytoMed Therapeutics Current Assets History

Loading

CytoMed Therapeutics vs. peers: Current Assets Comparison

Loading

CytoMed Therapeutics Current Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

CytoMed Therapeutics (GDTC) FAQ

As of the most recent data (December 2025), GDTC shows a current assets of $3.7M. That compares with $4.4M in the prior-year period — down 16.7% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, GDTC's current assets is now $3.7M (was $4.4M) — a 16.7% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether CytoMed Therapeutics is outperforming or lagging.

Tracking GDTC's current assets over time shows whether CytoMed Therapeutics is scaling, shrinking, or reshaping that part of the business. The current reading is $3.7M That compares with $4.4M in the prior-year period — down 16.7% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this current assets page, Stockcircle has CytoMed Therapeutics's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect current assets (currently $3.7M) with ownership activity and broader fundamentals.